Nov 06, 2024 / 10:00PM GMT
Operator
Good afternoon. Thank you for attending today's Arcus Biosciences third quarter, 2024 earnings call. My name is Tamia and I will be your moderator for today's call. (Operator Instructions)
I will now to pass the conference over to your host, Pia Eaves, Vice President of Investor Relations. You may proceed.
Pia Eaves - Arcus Biosciences Inc - Vice President of Investor Relations & Strategy
Hello, everyone and thank you for joining us on today's conference call to discuss Arcus's third quarter, 2024 financial results and pipeline updates including our upcoming presentation of ARC 10 data at C. I'd like to remind you that on this call management will make forward-looking statements including statements about our cash runway and our expected clinical development milestones and timelines. All statements other than historical facts reflect the current beliefs and expectations of management and involve risks and uncertainties that may cause our actual results to differ from those expressed, those risks and uncertainties are described in our most recent
Q3 2024 Arcus Biosciences Inc Earnings Call Transcript
Nov 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers